REGULATION OF GENE EXPRESSION BY NO/CGMP
NO/CGMP 对基因表达的调节
基本信息
- 批准号:6019266
- 负责人:
- 金额:$ 22.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography biological signal transduction cGMP dependent protein kinase chimeric proteins cyclic GMP enzyme activity enzyme mechanism enzyme substrate genetic enhancer element genetic promoter element genetic regulatory element immunofluorescence technique nitric oxide nucleic acid sequence oligonucleotides site directed mutagenesis transcription factor tumor necrosis factor alpha yeast two hybrid system
项目摘要
DESCRIPTION (Investigator's Abstract): The nitric oxide
(NO)cGMP/cGMP-dependent protein kinase (G-kinase) signal transduction
pathway is important for the regulation of many physiological and
pathophysiological processes, e.g., in the cardiovascular system it is a
major determinant of smooth muscle cell, endothelial cell and platelet
functions and is implicated in the development of hypertension and
atherosclerosis. However, compared to cAMP-dependent protein kinase, little
is known about the downstream effects of G-kinase activation. The
investigators found that G-kinase regulates gene expression: in response to
NO or cGMP, the kinase translocates to the nucleus, induces phosphorylation
of CREB-related proteins and activates the fos, junB and TNF-alpha
promoters. Preliminary data suggest that G-kinase transactivates these
promoters through similar cis-acting elements recognized by transcription
factors of the AP-1 (Fos-Jun), CRE- and CCAAT-enhancer binding protein
families and that subcellular localization and biological activity of the
kinase is regulated by specific anchoring proteins. The speciic aims of
this proposal are: (1) to define DNA sequences of NO/cGMP-response elements
(NGREs): (II) to identify transcription factors targeted by
NO/cGMP/G-kinase; and (III) to identify key substrates and cytoplasmic or
nuclear anchoring proteins which bind to G-kinase. NGREs will be defined by
deletion and site-directed mutagenesis of putative enhancer elements in the
fos and TNF-alpha promoters. Transcription factors targeted by NO/cGMP will
be identified in transactivation studies using Ga14-fusion products and
dominant negative mutants of candidate transcription factors as well as in
DNA binding studies and DNA affinity chromatography using
oligodeoxynucleotides encoding NGREs. Protein interaction cloning will be
employed to identify proteins interacting with G-kinase and the effect of
these proteins on subcellular localization and function of G-kinase will be
tested. The widespread importance of NO as a signaling molecule has been
recognized recently; the studies proposed in this grant application should
provide new insights into the mechanism of action of NO and cGMP in
mammalian cells. Since pharmacological manipulation of the NO/cGMP signal
transduction pathway offers therapeutic potential for a wide variety of
human diseases, a better understanding of the long-term downstream effects
of NO and cGMP is urgently needed.
描述(研究者摘要):一氧化氮
(NO)cGMP/cGMP 依赖性蛋白激酶(G-激酶)信号转导
途径对许多生理和功能的调节非常重要
病理生理过程,例如,在心血管系统中,它是
平滑肌细胞、内皮细胞和血小板的主要决定因素
功能并与高血压的发展有关
动脉粥样硬化。 然而,与 cAMP 依赖性蛋白激酶相比,很少
已知 G 激酶激活的下游效应。 这
研究人员发现 G-激酶调节基因表达:响应
NO 或 cGMP,激酶易位至细胞核,诱导磷酸化
CREB 相关蛋白并激活 fos、junB 和 TNF-α
发起人。 初步数据表明 G-激酶反式激活这些
通过转录识别的相似顺式作用元件启动子
AP-1 (Fos-Jun)、CRE 和 CCAAT 增强子结合蛋白的因子
家族以及亚细胞定位和生物活性
激酶受特定锚定蛋白调节。 具体目标
该提案是: (1) 定义 NO/cGMP 响应元件的 DNA 序列
(NGRE):(II) 识别目标转录因子
NO/cGMP/G-激酶; (III) 识别关键底物和细胞质或
与 G 激酶结合的核锚定蛋白。 NGRE 的定义为
假定的增强子元件的缺失和定点突变
fos 和 TNF-α 启动子。 NO/cGMP 靶向的转录因子将
在使用 Ga14 融合产物的反式激活研究中被识别,并且
候选转录因子的显性失活突变体以及
DNA 结合研究和 DNA 亲和层析使用
编码 NGRE 的寡脱氧核苷酸。 蛋白质相互作用克隆将
用于鉴定与 G 激酶相互作用的蛋白质以及
这些蛋白质对 G-激酶的亚细胞定位和功能的影响将是
已测试。 NO 作为信号分子的广泛重要性已被
最近被认可;本拨款申请中提出的研究应
为 NO 和 cGMP 的作用机制提供新的见解
哺乳动物细胞。 由于 NO/cGMP 信号的药理学操纵
转导途径为多种疾病提供了治疗潜力
人类疾病,更好地了解长期下游影响
迫切需要 NO 和 cGMP。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RENATE B PILZ其他文献
RENATE B PILZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RENATE B PILZ', 18)}}的其他基金
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
- 批准号:
10634657 - 财政年份:2021
- 资助金额:
$ 22.12万 - 项目类别:
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
- 批准号:
10296605 - 财政年份:2021
- 资助金额:
$ 22.12万 - 项目类别:
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
- 批准号:
10478942 - 财政年份:2021
- 资助金额:
$ 22.12万 - 项目类别:
Targeting defective NO/cGMP signaling as novel therapy for diabetic osteoporosis
针对缺陷的 NO/cGMP 信号作为糖尿病骨质疏松症的新疗法
- 批准号:
9899734 - 财政年份:2016
- 资助金额:
$ 22.12万 - 项目类别:
A novel treatment of aortic disease in Marfan Syndrome targeting oxidative stress and PKG dysregulation
针对氧化应激和 PKG 失调的马凡综合征主动脉疾病的新疗法
- 批准号:
10453951 - 财政年份:2016
- 资助金额:
$ 22.12万 - 项目类别:
Targeting defective NO/cGMP signaling as novel therapy for diabetic osteoporosis
针对缺陷的 NO/cGMP 信号作为糖尿病骨质疏松症的新疗法
- 批准号:
9459312 - 财政年份:2016
- 资助金额:
$ 22.12万 - 项目类别:
Targeting defective NO/cGMP signaling as novel therapy for diabetic osteoporosis
针对缺陷的 NO/cGMP 信号作为糖尿病骨质疏松症的新疗法
- 批准号:
9106282 - 财政年份:2016
- 资助金额:
$ 22.12万 - 项目类别:
A novel treatment of aortic disease in Marfan Syndrome targeting oxidative stress and PKG dysregulation
针对氧化应激和 PKG 失调的马凡综合征主动脉疾病的新疗法
- 批准号:
10588164 - 财政年份:2016
- 资助金额:
$ 22.12万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CmMYB整合生长素及乙烯信号转导因子调控菊花花青素苷生物合成的分子机制及网络解析
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目